Study of Dentoxol® Mouthrinse for Oral Mucositis
NCT02885376 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2018-12-21
Summary
The primary objective of this study is to determine the efficacy of Dentoxol® mouthrinse in reducing the severity of oral mucositis secondary to radiation therapy for head and neck cancer.
Conditions
- Oral Mucositis
Interventions
- DEVICE
-
Dentoxol
Mouthrinse
- DEVICE
-
Placebo
Mouthrinse
Sponsors & Collaborators
-
Ingalfarma SpA
lead INDUSTRY
Principal Investigators
-
Sebastián Sole · Clinica IRAM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2018-04-30
- Completion
- 2018-08-31
Countries
- Chile
Study Locations
More Related Trials
-
Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region
NCT01083875 ·Status: COMPLETED ·Phase: PHASE2
-
Herbal Mouthrinse for Oral Mucositis Study
NCT01898091 ·Status: COMPLETED ·Phase: PHASE2
-
Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy
NCT06708702 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis.
NCT05161091 ·Status: RECRUITING ·Phase: NA
-
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
NCT00293462 ·Status: COMPLETED ·Phase: PHASE3
-
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
NCT00022373 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of RK0202 in Oral Mucositis
NCT00230191 ·Status: COMPLETED ·Phase: PHASE2
-
EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer
NCT00574860 ·Status: TERMINATED ·Phase: PHASE3
-
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
NCT01156142 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.
NCT05635929 ·Status: RECRUITING ·Phase: NA
-
Ectoin® Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral Mucositis
NCT02816515 ·Status: COMPLETED
-
MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer
NCT03461354 ·Status: TERMINATED ·Phase: NA
-
Prevention of Oral Mucositis in Head and Neck Cancer.
NCT05853692 ·Status: RECRUITING ·Phase: NA
-
Low-Level Laser Therapy for Prevention of Oral Mucositis
NCT02723604 ·Status: COMPLETED ·Phase: NA
-
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
NCT02542215 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients
NCT05664906 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
NCT02069093 ·Status: COMPLETED ·Phase: PHASE2
-
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
NCT03200340 ·Status: COMPLETED ·Phase: PHASE2
-
Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy
NCT07287826 ·Status: RECRUITING ·Phase: PHASE4
-
Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis
NCT03720340 ·Status: UNKNOWN ·Phase: PHASE3
-
A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy
NCT06251050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Blinded Dry Mouth Spray Crossover Study
NCT04608773 ·Status: COMPLETED ·Phase: NA
-
Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation
NCT02630004 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
OZOCLO_MUCOSITIS: a New Protocol for Prevention of Oral Mucositis
NCT05211622 ·Status: UNKNOWN ·Phase: PHASE4
-
The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients
NCT01099891 ·Status: UNKNOWN ·Phase: PHASE3